Condition
Molecular Pathway Deregulation
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05365412Recruiting
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05364294Recruiting
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT06830590Recruiting
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Showing all 3 trials